InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 14.79
+0.32 (2.21%)
Sep 30, 2026, 4:08 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 29.89 billion as of September 29, 2026. Its market cap has decreased by -10.06% in one year.
Market Cap
29.89B
Enterprise Value
23.37B
Revenue
3.21B
Ranking
n/a
PE Ratio
24.80
Stock Price
14.79
ChartMarket Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 29.89B, an increase of 143.43%. That is a compound annual growth rate of 14.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 29.89B | 26.18% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 63.80B |
| Biocytogen Pharmaceuticals (Beijing) | 57.42B |
| 3SBio | 39.68B |
| Shanghai Junshi Biosciences | 35.83B |
| InSilico Medicine Cayman TopCo | 31.90B |
| Shanghai Henlius Biotech | 30.37B |
| Keymed Biosciences | 23.45B |
| Zai Lab | 22.63B |